Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Short-Sellers Stay Strong on Tilray Stock, Await January Judgment

Shorts aren't shying away from the cannabis industry even after a series of squeezes.

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray Stock Higher Ahead of First Post-Legalization Earnings Release

Tilray will have a lot to tackle this evening.

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray

With Tilray set to report earnings after today's closing bell, we're rewinding to our sit-down with CEO Brendan Kennedy.

Aurora Cannabis Tanks Despite Strong Earnings Growth

Aurora Cannabis Tanks Despite Strong Earnings Growth

Aurora Cannabis reports fiscal first-quarter revenue growth of 260%.

Jim Cramer's Take on the Cannabis Craze

Jim Cramer's Take on the Cannabis Craze

Another cannabis craze?

Jim Cramer Talks Take-Two and What's Next for Cannabis

Jim Cramer Talks Take-Two and What's Next for Cannabis

Jim Cramer takes a look at video game stocks, the cannabis craze and answers a question from a viewer.

IGC, Tilray and Other Pot Stocks Gain After Sessions Quits as Attorney General

IGC, Tilray and Other Pot Stocks Gain After Sessions Quits as Attorney General

IGC and Tilray rise by double-digit percentages and other weed stocks rally as anti-pot attorney general steps down and voters back cannabis sales in three states.

Pot Stocks Pop After Michigan Legalizes Recreational Cannabis Use

Pot Stocks Pop After Michigan Legalizes Recreational Cannabis Use

Michigan becomes the 10th U.S. state to legalize the recreational use of marijuana.

Out-of-Stock Levels Are High for Recreational Cannabis in Canada

Out-of-Stock Levels Are High for Recreational Cannabis in Canada

An early look at the market shows supply is finding it tough to keep up with demand.

CV Sciences CEO on the Future of CBD in Healthcare

CV Sciences CEO on the Future of CBD in Healthcare

CV Sciences CEO discusses the medical applications of CBD at Jim Cramer's teach in.